Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension.

Autor: Reddy TP; Texas A&M University School of Medicine Bryan Texas USA.; Houston Methodist Research Institute Houston Texas USA., Barrios R; Department of Pathology and Genomic Medicine Houston Methodist Hospital Houston Texas USA., Bernicker E; Medical Oncology Centura Health Denver Colorado USA., Qian W; Houston Methodist Research Institute Houston Texas USA., Chang J; Houston Methodist Research Institute Houston Texas USA.; Houston Methodist Neal Cancer Center Houston Texas USA., Safdar Z; Houston Methodist Research Institute Houston Texas USA.; Pulmonary Hypertension Center at Houston Methodist Lung Center Houston Methodist Hospital, Weill Cornell College of Medicine Houston Texas USA.

Publikováno v: Pulmonary circulation [Pulm Circ] 2024 Sep 02; Vol. 14 (3), pp. e12426. Date of Electronic Publication: 2024 Sep 02 (Print Publication: 2024).

Climate Change and Cancer Care: A Policy Statement From ASCO.

Autor: Bernicker E; CommonSpiritHealth, Chicago, IL., Averbuch SD; SD Averbuch Consulting LLC, Princeton, NJ., Edge S; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Kamboj J; Mayo Clinic, Rochester, MN., Khuri FR; American University of Beirut, Beirut, Lebanon., Pierce JY; University of South Alabama, Mobile, AL., Schiller J; University of Virginia, Charlottesville, VA., Sirohi B; BALCO Medical Centre, Naya Raipur, India., Thomas A; Wake Forest University School of Medicine, Winston-Salem, NC., Moushey A; American Society of Clinical Oncology, Alexandria, VA., Phillips J; American Society of Clinical Oncology, Alexandria, VA., Hendricks C; Maryland Oncology, Bethesda, MD.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Feb; Vol. 20 (2), pp. 178-186. Date of Electronic Publication: 2023 Nov 27.

Incidence and outcome of immune checkpoint-induced pneumonitis in oncology patients with history of pulmonary disease.

Autor: Allen E; Hematology/Oncology Department, Houston Methodist Hospital Texas Medical Center, Houston, TX, United States., Umoru G; Hematology/Oncology Department, Houston Methodist Hospital Texas Medical Center, Houston, TX, United States., Ajewole V; Hematology/Oncology Department, Houston Methodist Hospital Texas Medical Center, Houston, TX, United States.; Texas State University College of Pharmacy and Health Sciences, Houston, TX, United States., Bernicker E; Hematology/Oncology Department, Houston Methodist Hospital Texas Medical Center, Houston, TX, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Oct 24; Vol. 13, pp. 1283360. Date of Electronic Publication: 2023 Oct 24 (Print Publication: 2023).

Comparison of Tumor Size and Gene Expression at Presentation in Uveal Melanoma Patients before and during the COVID-19 Pandemic.

Autor: Hasegawa N; aDepartment of Ophthalmology, University of Texas at Houston, Houston, Texas, USA., Rusakevich A; bRetina Consultants of Texas, Houston, Texas, USA., Bernicker E; cHouston Methodist Cancer Center, Houston Methodist Hospital, Houston, Texas, USA., Teh BS; dDepartment of Radiation Oncology, Houston Methodist Hospital, Houston, Texas, USA., Schefler A; bRetina Consultants of Texas, Houston, Texas, USA.

Publikováno v: Ocular oncology and pathology [Ocul Oncol Pathol] 2022 Nov; Vol. 8 (3), pp. 156-160. Date of Electronic Publication: 2022 May 09.

A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.

Autor: Chung AW; Texas A&M University Health Science Center, Bryan, TX 77807, USA.; Houston Methodist Research Institute, Houston, TX 77030, USA.; Houston Methodist Cancer Center, Houston, TX 77030, USA., Anand K; Houston Methodist Cancer Center, Houston, TX 77030, USA., Anselme AC; Texas A&M University Health Science Center, Bryan, TX 77807, USA.; Houston Methodist Research Institute, Houston, TX 77030, USA.; Houston Methodist Cancer Center, Houston, TX 77030, USA., Chan AA; Lundquist Institute, Torrance, CA 90502, USA., Gupta N; Department of Radiology, Houston Methodist Hospital, Houston, TX 77030, USA., Venta LA; Department of Radiology, Houston Methodist Hospital, Houston, TX 77030, USA., Schwartz MR; Houston Methodist Department of Pathology and Genomic Medicine, Houston, TX 77030, USA., Qian W; Houston Methodist Research Institute, Houston, TX 77030, USA.; Houston Methodist Cancer Center, Houston, TX 77030, USA., Xu Y; Houston Methodist Research Institute, Houston, TX 77030, USA.; Houston Methodist Cancer Center, Houston, TX 77030, USA., Zhang L; Houston Methodist Research Institute, Houston, TX 77030, USA.; Houston Methodist Cancer Center, Houston, TX 77030, USA., Kuhn J; University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA., Patel T; Houston Methodist Cancer Center, Houston, TX 77030, USA.; Department of General Oncology MD Anderson Cancer Center, Houston, TX 77030, USA., Rodriguez AA; Austin Cancer Center, Austin, TX 78705, USA., Belcheva A; Houston Methodist Cancer Center, Houston, TX 77030, USA., Darcourt J; Houston Methodist Cancer Center, Houston, TX 77030, USA., Ensor J; Houston Methodist Cancer Center, Houston, TX 77030, USA., Bernicker E; Houston Methodist Cancer Center, Houston, TX 77030, USA., Pan PY; Houston Methodist Research Institute, Houston, TX 77030, USA.; Houston Methodist Cancer Center, Houston, TX 77030, USA., Chen SH; Houston Methodist Research Institute, Houston, TX 77030, USA.; Houston Methodist Cancer Center, Houston, TX 77030, USA., Lee DJ; Lundquist Institute, Torrance, CA 90502, USA.; David Geffen School of Medicine at Los Angeles, CA 90095, USA., Niravath PA; Houston Methodist Cancer Center, Houston, TX 77030, USA., Chang JC; Houston Methodist Research Institute, Houston, TX 77030, USA.; Houston Methodist Cancer Center, Houston, TX 77030, USA.

Publikováno v: Science translational medicine [Sci Transl Med] 2021 Dec 15; Vol. 13 (624), pp. eabj5070. Date of Electronic Publication: 2021 Dec 15.